 |
Glyeraldehyde-3-phosphate dehydrogenase |
|---|---|
| Trade Name | Proenzy |
| Orphan Indication | Pediatric multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | BPT Pharmaceuticals, Inc.;743 North Sweetzer Avenue #103;Los Angeles, California, 90069 |
